| Lymphedema After Urologic Surgery (NCT05264337) | Vastra Gotaland Region | 2022-03-14 |
| Effect of Online Education Given to Young Adults on Testicular Cancer Health Beliefs and Behaviors (NCT05056688) | Agri Ibrahim Cecen University | 2021-04-30 |
| Role of Axumin PET Scan in Germ Cell Tumor (NCT03426865) | University of Texas Southwestern Medical Center | 2018-03-01 |
| Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy (NCT02492360) | Costantine Albany | 2017-12-01 |
| Avelumab in Refractory Testicular Germ Cell Cancer. (NCT03403777) | National Cancer Institute, Slovakia | 2017-11-15 |
| CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice (NCT02900248) | CureOne | 2017-10-02 |
| Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours (NCT04122430) | Walter and Eliza Hall Institute of Medical Research | 2015-12-01 |
| Testicular Cancer and Aerobic and Strength Training (NCT02577172) | Oslo University Hospital | 2015-11-01 |
| High-Intensity Aerobic Interval Training in Testicular Cancer Survivors (NCT02459132) | University of Alberta | 2015-07-01 |
| The Platinum Study Comparison Group (NCT02890030) | Lawrence Einhorn | 2015-05-01 |
| Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer (NCT02341989) | St. Olavs Hospital | 2015-04-08 |
| Quality of Life Among Testicular Cancer Survivors (NCT02304575) | Rabin Medical Center | 2015-01-01 |
| Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS (NCT02229916) | Dr. med. Christian Rothermundt | 2013-12-01 |
| Engagement of Patients With Advanced Cancer (NCT02966509) | Stanford University | 2013-08-01 |
| GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT) (NCT06309732) | Queen Mary University of London | 2006-07-01 |
| High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II (NCT00231582) | Assistance Publique - Hôpitaux de Paris | 2004-09-01 |
| Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors (NCT02161692) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1996-12-01 |
| Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma (NCT00001270) | National Cancer Institute (NCI) | 1991-06-01 |